Cadrenal Therapeutics
Cadrenal Therapeutics is a biopharmaceutical company developing a late-stage novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism, more commonly referred to as blood clots, of cardiac origin in patients with end-stage renal disease and atrial fibrillation (ESRD + AFib).
Industry
Pharmaceutical
Corporate Phone Number
(904) 300-0701
Customer Support Phone Number
N/A
Headquartered Address
822 A1A North, Suite 320, Ponte Vedra,
Florida 32082
Email:
N/A
Website:
This website provides the most important contact information about the Corporate Offices & Headquarters including Cadrenal Therapeutics Address, Corporate Number, and more.
